Curcumin-Loaded Polymeric Nanoparticle: A Promising Route for the Treatment of Cancer

2015 ◽  
pp. 202-233
2017 ◽  
Vol 68 (2) ◽  
pp. 203-209
Author(s):  
Hussam Nadum Abdalraheem Al Ani ◽  
Anca Maria Cimbru ◽  
Corneliu Trisca-Rusu ◽  
Szidonia Katalin Tanczos ◽  
Adriana Cuciureanu ◽  
...  

This paper illustrates the possibility of producing iono-molecular separations using ionic colloidal ultrafiltration membrane of polysulfone synthetic solutions of cupric ions and nitro phenols through ultrafiltration assisted by polymeric nanoparticle composites based on polysulfone. In the present work, in order to reduce the operating pressure and increase the flow of water we are using the process of ultrafiltration through a polysulfone membrane in N-methylpyrrolidone 10% prepared by coagulation in isopropanol. The nanoparticles needed in colloidal ultrafiltration had been obtained through the immersion technique of precipitation of a solution of 5% PSf in N-methyl pyrrolidone containing 3% aniline in lower alcohols: methanol, ethanol, and isopropanol, followed by the oxidation of the remaining aniline in a solution of 10% hydrochloric acid and ammonium persulfate. The Nanoparticles of polysulfone (NP-PSf) and The three obtained variants of nanoparticles composites (NP-PSf-PANI) were morphologically (SEM) and (AFM), structurally and compositionally (FTIR) characterized and the results show that nanoparticles polysulfone have a much lower range than the composites. The Possibility of copper complexation by both nitrophenols, and by nanoparticle surface probably lead to the formation of more stable aggregates in the supply, which can sufficiently justify the increased retention. The Retentions of the chemical species in question use in all the tests made the same series:R NP-PSf-PANI-M] R NP-PSf-PANI-E] R NP-PSf-PANI-P] R NP-PSf


2020 ◽  
Vol 21 (9) ◽  
pp. 649-660
Author(s):  
Subashini Raman ◽  
Syed Mahmood ◽  
Ayah R. Hilles ◽  
Md Noushad Javed ◽  
Motia Azmana ◽  
...  

Background: Blood-brain barrier (BBB) plays a most hindering role in drug delivery to the brain. Recent research comes out with the nanoparticles approach, is continuously working towards improving the delivery to the brain. Currently, polymeric nanoparticle is extensively involved in many therapies for spatial and temporal targeted areas delivery. Methods: We did a non-systematic review, and the literature was searched in Google, Science Direct and PubMed. An overview is provided for the formulation of polymeric nanoparticles using different methods, effect of surface modification on the nanoparticle properties with types of polymeric nanoparticles and preparation methods. An account of different nanomedicine employed with therapeutic agent to cross the BBB alone with biodistribution of the drugs. Results: We found that various types of polymeric nanoparticle systems are available and they prosper in delivering the therapeutic amount of the drug to the targeted area. The effect of physicochemical properties on nanoformulation includes change in their size, shape, elasticity, surface charge and hydrophobicity. Surface modification of polymers or nanocarriers is also vital in the formulation of nanoparticles to enhance targeting efficiency to the brain. Conclusion: More standardized methods for the preparation of nanoparticles and to assess the relationship of surface modification on drug delivery. While the preparation and its output like drug loading, particle size, and charge, permeation is always conflicted, so it requires more attention for the acceptance of nanoparticles for brain delivery.


ACS Omega ◽  
2020 ◽  
Vol 5 (50) ◽  
pp. 32366-32372
Author(s):  
Jie Yu ◽  
Mingwei Wang ◽  
Rizwan Ahmed Bhutto ◽  
Hongyang Zhao ◽  
Martien A. Cohen Stuart ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Yu-Li Lo ◽  
Hua-Ching Lin ◽  
Shu-Ting Hong ◽  
Chih-Hsien Chang ◽  
Chen-Shen Wang ◽  
...  

Abstract Background Brain metastases from non-small cell lung cancer (NSCLC) remain one of the most challenging malignancies. Afatinib (Afa) is an orally administered irreversible ErbB family blocker approved for epidermal growth factor receptor (EGFR)-mutated NSCLC. However, the incidence of brain metastases in patients with NSCLC and EGFR mutation is high. One of the major obstacles in the treatment of brain metastases is to transport drugs across the blood–brain barrier (BBB). A lipid polymeric nanoparticle (LPN) modified with a tight junction-modulating peptide is a potential formulation to deliver therapeutics across the BBB. FD7 and CCD are short peptides that perturb the tight junctions (TJs) of the BBB. In this study, the use of LPN modified with FD7 or CCD as a delivery platform was explored to enhance Afa delivery across the BBB model of mouse brain-derived endothelial bEnd.3 cells. Results Our findings revealed that Afa/LPN-FD7 and Afa/LPN-CCD exhibited a homogeneous shape, a uniform nano-scaled particle size, and a sustained-release profile. FD7, CCD, Afa/LPN-FD7, and Afa/LPN-CCD did not cause a significant cytotoxic effect on bEnd.3 cells. Afa/LPN-FD7 and Afa/LPN-CCD across the bEnd.3 cells enhanced the cytotoxicity of Afa on human lung adenocarcinoma PC9 cells. FD7 and CCD-modulated TJ proteins, such as claudin 5 and ZO-1, reduced transendothelial electrical resistance, and increased the permeability of paracellular markers across the bEnd.3 cells. Afa/LPN-FD7 and Afa/LPN-CCD were also partially transported through clathrin- and caveolae-mediated transcytosis, revealing the effective activation of paracellular and transcellular pathways to facilitate Afa delivery across the BBB and cytotoxicity of Afa on PC9 cells. Conclusion TJ-modulating peptide-modified LPN could be a prospective platform for the delivery of chemotherapeutics across the BBB to the brain for the potential treatment of the BM of NSCLC.


Author(s):  
Michael W. Favoreto ◽  
Mariniella P. Madureira ◽  
Viviane Hass ◽  
Bianca M. Maran ◽  
Sibelli O. Parreiras ◽  
...  

2004 ◽  
Vol 76 (9) ◽  
pp. 2649-2655 ◽  
Author(s):  
Jongwon Park ◽  
Shigeru Kurosawa ◽  
Junji Watanabe ◽  
Kazuhiko Ishihara

Sign in / Sign up

Export Citation Format

Share Document